Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical precision. Across operating rooms, scanners, and even blood tests, ...

Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and ...

BriaCell (BCTX) Therapeutics announces that its subsidiary, BriaPro Therapeutics, has initiated a research collaboration with Receptor.AI, an AI-driven drug discovery company, to design anti-cancer ...

The need to improve the detection of breast cancer in women with dense breasts has resulted in the use of additional imaging modalities to supplement screening. Supplemental molecular breast imaging ...

Molecular ESR1 changes may signal symptomatic progression before imaging in metastatic breast cancer, supporting camizestrant for improved quality of life.

Triple-negative breast cancer (TNBC) is exceptionally difficult to treat, in part because the cancer cells lack the hormone receptors that are targeted by many therapies. But now, scientists led by ...

LOS ANGELES & RESTON, Va.--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced a collaboration that will provide funding and ...

News Medical talks to Samuel Penwell and Winfried Wiegraebe about how the Vutara VXL enables robust, high-throughput 3D super-resolution via single-molecule localization, pairing bi-plane detection ...